Eli Lilly (LLY) established a commercial alliance covering the marketing, distribution, and sale of its pharmaceutical products in Hong Kong and Macau, DKSH said Monday.
The partnership broadens previous commercial collaborations between the two businesses within Vietnam and Singapore, the company said.
The distributor will also maintain current international safety monitoring, quality control, and pharmacovigilance standards for the medicines, DKSH said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.